Evidence map›Paper›PMID 38427715›Full record

ArticleThe Journal of infectious diseases2024

Relationship Between Hepatitis C Infection and Treatment Status and Coronavirus Disease 2019-Related Hospitalizations in Georgia.

Ana Aslanikashvili, Charlotta Rylander, Tinatin Manjavidze, Amiran Gamkrelidze, Davit Baliashvili, Erik Eik Anda

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Ana AslanikashviliDepartment of Community Medicine, University of Tromsø-The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0002-9311-2495
Charlotta RylanderDepartment of Community Medicine, University of Tromsø-The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0002-5056-9452
Tinatin ManjavidzeDepartment of Community Medicine, University of Tromsø-The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0003-1340-6256
Amiran GamkrelidzeSchool of Health Sciences, University of Georgia, Tbilisi, Georgia.ORCID 0000-0002-9767-978X
Davit BaliashviliTask Force for Global Health, Tbilisi, Georgia.ORCID 0000-0001-8390-3325
Erik Eik AndaDepartment of Community Medicine, University of Tromsø-The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0002-7933-2459
UiT The Arctic University of Norway · NONational Center for Disease Control and Public Health · GEThe Task Force for Global Health · USUniversity of Georgia · GE

Funding

Emory-Georgia TB Research Training ProgramD43TW007124 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Nestani Tukvadze · 2004 to 2026
$4.6M
FIC NIH HHS D43 TW007124University of Tromsø-The Arctic University of Norway 31122200
6 · The paper itself

Abstract

backgroundThe aim of this study was to evaluate the impact of hepatitis C virus (HCV) infection and treatment status on coronavirus disease 2019 (COVID-19)-related hospitalizations in Georgia.

methodsWe analyzed 2020-2021 Georgian health registry data for COVID-19-positive individuals and categorized the data by HCV infection and treatment status. Logistic regression was used to assess the strengths of the associations.

resultsTreated individuals with HCV had lower odds of COVID-19-related hospitalization compared to anti-HCV-negative individuals, while untreated HCV-viremic and anti-HCV-positive nonviremic individuals had higher odds.

conclusionsHCV treatment prior to COVID-19 infection was associated with lower odds of COVID-19-related hospitalization, highlighting the benefits of HCV management in the context of the pandemic.

Indexed as

COVID-19Hepatitis CHospitalizationSARS-CoV-2AdolescentAdultAgedAntiviral AgentsFemaleGeorgiaGeorgia (Republic)HepacivirusHumansMaleMiddle AgedYoung AdultAntiviral AgentsCOVID-19direct-acting antiviralsGeorgiahepatitis C virusregistry study

Identifiers

PMID38427715
PMCPMC11420765
OpenAlexW4392344423

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.